𝔖 Bobbio Scriptorium

✦ LIBER ✦

Optimizing Outcomes in Hepatitis C: Is Treatment Beyond 48 Weeks Ever Justified?

✍ Scribed by Robert J. Fontana

Book ID: 119759163
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 103 KB
Volume: 130
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2006.02.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1065 Longer Therapy With 48 Weeks of P

Su1065 Longer Therapy With 48 Weeks of Pegylated Interferon and Ribavirin (PEG IFN+RBV) Is Superior to 24 Weeks in Patients With Treatment-Naive Hepatitis C Virus Genotype 6 (HCV-6): A Meta-Analysis of 641 Patients

✍ Nguyen, Nghia; McCormack, Shelley A.; Yee, Brittany E.; Nguyen, Mindie H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB